SciELO - Scientific Electronic Library Online

 
vol.16 número2Perspectives on NASH Histology: Cellular BallooningCombination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Annals of Hepatology

versión impresa ISSN 1665-2681

Resumen

MORALES, María Luisa; SENDRA, Carmen  y  ROMERO-GOMEZ, Manuel. Hepatitis B and NAFLD: Lives Crossed. Ann. Hepatol. [online]. 2017, vol.16, n.2, pp.185-187. ISSN 1665-2681.  http://dx.doi.org/10.5604/16652681.1231556.

Hepatitis B virus infection seems to protect against steatosis and insulin resistance decreasing NAFLD. Metabolic syndrome has been associated with increased risk of disease progression to cirrhosis and liver cancer in hepatitis B. HBsAg seroclearance increased over time and it could be a confounding factor when analysing NAFLD and hepatitis B prevalence.

Palabras llave : Hepatitis B; HBsAg; HBeAg; NAFLD; NASH.

        · texto en Inglés     · Inglés ( pdf )